Effects of Feeding Bt Maize to Sows during Gestation and Lactation on Maternal and Offspring Immunity and Fate of Transgenic Material

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Buzoianu, Stefan G ^a,b   Walsh, Maria C ^a   Rea, Mary C ^c,d   O'Donovan, Orla ^b   Gelencsér, Eva ^e   Ujhelyi, Gabriella ^e   Szabó, Erika ^e   Nagy, Andras ^e   Ross, R Paul ^c,d   Gardiner, Gillian E ^b   Lawlor, Peadar G ^a  

^a ANIMAL AND GRASSLAND RESEARCH AND INNOVATION CENTRE   (Ireland)

^b Ireland   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^d UNIVERSITY COLLEGE CORK   (Ireland)

^e CENTRAL FOOD RESEARCH INSTITUTE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CRY1AB TOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; ARTIFICIAL INSEMINATION; BLOOD; BREEDING; CD4 CD8 RATIO; CELL COUNT; CONTROLLED STUDY; CRY1AB GENE; CYTOKINE PRODUCTION; FECES; FEMALE; FOOD INTAKE; GENE; GENETICALLY MODIFIED FOOD; GRANULOCYTE; HEMATOLOGY; IMMUNITY; LACTATION; LEUKOCYTE; LYMPHOCYTE COUNT; MAIZE; MATERNAL NUTRITION; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROGENY; SOW (SWINE); TRANSGENE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; CYTOKINES; DIET; ENDOTOXINS; FEMALE; LACTATION; LEUKOCYTES, MONONUCLEAR; PLANTS, GENETICALLY MODIFIED; PREGNANCY; SWINE; ZEA MAYS;

EID: 84867592532     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047851     Document Type: Article

References (60)

1. James C (2010) Global status of commercialized biotech/GM crops: 2010. ISAAA Brief No. 42. Ithaca, NY, USA. 241 p.
2. Dona A, Arvanitoyannis IS, (2009) Health risks of genetically modified foods. Crit Rev Food Sci Nutr 49: 164-175.
3. Gaskell G (2005) Europeans and biotechnology in 2005: patterns and trends. A report to the European Commission's Directorate-General for Research.
4. Gaskell G, Stares S, Allansdottir A, Allum N, Castro P, et al. (2010) EUR24537- Europeans and biotechnology in 2010 winds of change? Luxembourg: Publications Office of the European Union. 172 p.
5. Schnepf E, Crickmore N, Van Rie J, Lereclus D, Baum J, et al. (1998) Bacillus thuringiensis and its pesticidal crystal proteins. Microbiol Rev 62: 775-806.
6. Hill M, Launis K, Bowman C, McPherson K, Dawson J, et al. (1995) Biolistic introduction of a synthetic Bt gene into elite maize. Euphytica 85: 119-123.
7. Betz FS, Hammond BG, Fuchs RL, (2000) Safety and advantages of Bacillus thuringiensis-protected plants to control insect pests. Regul Toxicol Pharmacol 32: 156-173.
8. Prescott VE, Hogan SP, (2006) Genetically modified plants and food hypersensitivity diseases: Usage and implications of experimental models for risk assessment. Pharmacol Ther 111: 374-383.
9. Wal JM, Hepburn PA, Lea LJ, Crevel RWR, (2003) Post-market surveillance of GM foods: applicability and limitations of schemes used with pharmaceuticals and some non-GM novel foods. Regul Toxicol Pharmacol 38: 98-104.
10. EFSA (2008) Safety and nutritional assessment of GM plants and derived food and feed: The role of animal feeding trials. Food Chem Toxicol 46: S2-S70.
11. Poole J, Claman H, (2004) Immunology of pregnancy. Clin Rev Allergy Immunol 26: 161-170.
12. Butts CL, Sternberg EM, (2008) Neuroendocrine factors alter host defense by modulating immune function. Cell Immunol 252: 7-15.
13. EFSA (2009) Scientific opinion of the panel on genetically modified organisms on applications (EFSA-GMO-RX-MON810) for the renewal of authorisation for the continued marketing of (1) existing food and food ingredients produced from genetically modified insect resistant maize MON810; (2) feed consisting of and/or containing maize MON810, including the use of seed for cultivation; and of (3) food and feed additives, and feed materials produced from maize MON810, all under Regulation (EC) No 1829/2003 from Monsanto. The EFSA Journal 1149: 1-85.
14. Domingo JL, Giné Bordonaba J, (2011) A literature review on the safety assessment of genetically modified plants. Environ Int 37: 734-742.
15. Snell C, Bernheim A, Berge J-B, Kuntz M, Pascal G, et al. (2012) Assessment of the health impact of GM plant diets in long-term and multigenerational animal feeding trials: A literature review. Food Chem Toxicol 50: 1134-1148.
16. Moughan PJ, Birtles MJ, Cranwell PD, Smith WC, Pedraza M, (1992) The piglet as a model animal for studying aspects of digestion and absorption in milk-fed human infants. World Rev Nutr Diet 67: 40-113.
17. Kararli TT, (1995) Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm Drug Dispos 16: 351-380.
18. Lewis AJ, Southern LL, editors (2001) Swine Nutrition. 2nd Edition ed. Boca Raton, FL, USA: CRC Press. 1009 p.
19. Walsh MC, Buzoianu SG, Gardiner GE, Cassidy JP, Rea MC, et al. (2012) Effects of short-term feeding of Bt MON810 maize on growth performance, organ morphology and function in pigs. Br J Nutr 107: 364-371.
20. NRC (1998) Nutrient requirements of swine. Washington, DC, USA: National Academy of Sciences. 189 p.
21. Hartnell GF, Cromwell GL, Dana GR, Lewis AJ, Baker DH, et al. (2007) Best practices for the conduct of animal studies to evaluate crops genetically modified for output traits; International Life Sciences Institute, editor. Washington, DC, USA. 194 p.
22. Walsh MC, Gardiner GE, Hart OM, Lawlor PG, Daly M, et al. (2008) Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype. FEMS Microbiol Ecol 64: 317-327.
23. Walsh MC, Buzoianu SG, Gardiner GE, Rea MC, Gelencsér E, et al. (2011) Fate of transgenic DNA from orally administered Bt MON810 maize and effects on immune response and growth in pigs. PLoS ONE 6: 11 e27177.
24. Walsh MC, Buzoianu SG, Rea MC, O'Donovan O, Gelencsér E, et al. (2012) Effects of feeding Bt MON810 maize to pigs for 110 days on peripheral immune response and digestive fate of the cry1ab gene and truncated Bt toxin. PLoS ONE 7: e36141.
25. SAS/STAT 9.22 (2010) User's Guide. Cary, NC, USA: SAS Institute Inc.
26. Osborne JW (2010) Improving your data transformations: applying the Box-Cox transformation. Practical Assessment, Research & Evaluation 15.
27. Littell RC, Milliken GA, Stroup WW, Wolfinger RD (1996) SAS system for mixed models. Cary, NC, USA: SAS Institute. 633 p.
28. Pappas PA, DePuy V, (2004) An overview of non-parametric tests in SAS: when, why, and how. SESUG 2004: The Proceedings of the SouthEast SAS Users Group, Nashville,TN 2004: TU04.
29. Mundry R, Fischer J, (1998) Use of statistical programs for nonparametric tests of small samples often leads to incorrect P values: examples from Animal Behaviour. Anim Behav 56: 256-259.
30. de Vendômois J, Cellier D, Vélot C, Clair E, Mesnage R, et al. (2010) Debate on GMOs health risks after statistical findings in regulatory tests. Int J Biol Sci. 6: 590-598.
31. EFSA (2011) Guidance for risk assessment of food and feed from genetically modified plants. The EFSA Journal 9: 2150.
32. Helm RM, Furuta GT, Stanley JS, Ye J, Cockrell G, et al. (2002) A neonatal swine model for peanut allergy. J Allergy Clin Immunol 109: 136-142.
33. Bailey M, Haverson K, (2006) The postnatal development of the mucosal immune system and mucosal tolerance in domestic animals. Vet Res 37: 443-453.
34. Walsh MC, Buzoianu SG, Gardiner GE, Rea MC, O'Donovan O,et al. (in press) Effects of feeding Bt MON810 maize to sows during first gestation and lactation on maternal and offspring health indicators. Br J Nutr DOI 10.1017/S0007114512002607.
35. Helm RM, Burks AW, (2000) Mechanisms of food allergy. Curr Opin Immunol 12: 647-653.
36. Janeway CA, Travers P, Walport M, Shlomchick Mark J, editors (2001) Immunobiology: the immune system in health and disease. NY: Garland Publishing. 732 p.
37. Chowdhury EH, Kuribara H, Hino A, Sultana P, Mikami O, et al. (2003) Detection of corn intrinsic and recombinant DNA fragments and Cry1Ab protein in the gastrointestinal contents of pigs fed genetically modified corn Bt11. J Anim Sci 81: 2546-2551.
38. Einspanier R, Lutz B, Rief S, Berezina O, Zverlov V, et al. (2004) Tracing residual recombinant feed molecules during digestion and rumen bacterial diversity in cattle fed transgene maize. Eur Food Res Technol 218: 269-273.
39. Lutz B, Wiedemann S, Einspanier R, Mayer J, Albrecht C, (2005) Degradation of Cry1Ab protein from genetically modified maize in the bovine gastrointestinal tract. J Agric Food Chem 53: 1453-1456.
40. Wiedemann S, Lutz B, Albrecht C, Kuehn R, Killermann B, et al. (2009) Fate of genetically modified maize and conventional rapeseed, and endozoochory in wild boar (Sus scrofa). Mamm Biol 74: 191-197.
41. Reddy NRJ, Borgs P, Wilkie BN, (2000) Cytokine mRNA expression in leukocytes of efferent lymph from stimulated lymph nodes in pigs. Vet Immunol Immunopathol 74: 31-46.
42. Murtaugh MP, Foss DL, (2002) Inflammatory cytokines and antigen presenting cell activation. Vet Immunol Immunopathol 87: 109-121.
43. Finamore A, Roselli M, Britti S, Monastra G, Ambra R, et al. (2008) Intestinal and peripheral immune response to MON810 maize ingestion in weaning and old mice. J Agric Food Chem 56: 11533-11539.
44. Barros E, Lezar S, Anttonen MJ, van Dijk JP, Röhlig RM, et al. (2010) Comparison of two GM maize varieties with a near-isogenic non-GM variety using transcriptomics, proteomics and metabolomics. Plant Biotechnol J 8: 436-451.
45. Batista R, Oliveira M, (2010) Plant natural variability may affect safety assessment data. Regulatory Toxicology and Pharmacology 58: S8-S12.
46. Fonseca Ct, Planchon S, Renaut J, Oliveira MM, Batista R, (2012) Characterization of maize allergens- MON810 vs. its non-transgenic counterpart. J Proteomics 75: 2027-2037.
47. Shoelson SE, Lee J, Goldfine AB, (2006) Inflammation and insulin resistance. J Clin Invest 116: 1793-1801.
48. Szczepanik M, (2006) Interplay between Helicobacter pylori and the immune system. Clinical implications. J Physiol Pharmacol 57 (Suppl 3):: 15-27.
49. Mukhopadhya I, Hansen R, El-Omar EM, Hold GL, (2012) IBD-what role do Proteobacteria play? Nat Rev Gastroenterol Hepatol 9: 219-230.
50. Feldman BV, Zinkl JG, Jain NC (2006) Schalm's Veterinary Hematology. Oxford, UK: Blackwell Publishing. 1344 p.
51. Egeli AK, Framstad T, Morberg H, (1998) Clinical biochemistry, haematology and body weight in piglets. Acta Vet Scand 39: 381-393.
52. Trabalza-Marinucci M, Brandi G, Rondini C, Avellini L, Giammarini C, et al. (2008) A three-year longitudinal study on the effects of a diet containing genetically modified Bt176 maize on the health status and performance of sheep. Livest Sci 113: 178-190.
53. Adel-Patient K, Guimaraes VD, Paris A, Drumare M-F, Ah-Leung S, et al. (2011) Immunological and metabolomic impacts of administration of Cry1Ab protein and MON 810 maize in mouse. PLoS ONE 6: e16346.
54. Takeshita H, Mogi K, Yasuda T, Nakajima T, Nakashima Y, et al. (2000) Mammalian deoxyribonucleases I are classified into three types: pancreas, parotid, and pancreas-parotid (mixed), based on differences in their tissue concentrations. Biochem Biophys Res Commun 269: 481-484.
55. Einspanier R, Klotz A, Kraft J, Aulrich K, Poser R, et al. (2001) The fate of forage plant DNA in farm animals: a collaborative case-study investigating cattle and chicken fed recombinant plant material. Eur Food Res Technol 212: 129-134.
56. Mazza R, Soave M, Morlacchini M, Piva G, Marocco A, (2005) Assessing the transfer of genetically modified DNA from feed to animal tissues. Transgenic Res 14: 775-784.
57. Patterson JK, Lei XG, Miller DD, (2008) The pig as an experimental model for elucidating the mechanisms governing dietary influence on mineral absorption. Exp Biol Med 233: 651-664.
58. Lehrer SB, McClain S, (2009) Utility of animal models for predicting human allergenicity. Regul Toxicol Pharmacol 54: S46-S51.
59. Bailey M, (2009) The mucosal immune system: Recent developments and future directions in the pig. Dev Comp Immunol 33: 375-383.
60. Rothkötter H-J, (2009) Anatomical particularities of the porcine immune system- A physician's view. Dev Comp Immunol 33: 267-272.